Biden wants a re­view of the API sup­ply chain. Will that par­lay in­to an ef­fort to 'on­shore' drug man­u­fac­tur­ing?

When for­mer Pres­i­dent Don­ald J. Trump was vot­ed out of of­fice Nov. 2, his gung-ho ef­fort to “on­shore” drug man­u­fac­tur­ing was left most­ly up in the air. Joe Biden has been most­ly mum on whether he would con­tin­ue that ef­fort, but a new ex­ec­u­tive or­der could pro­vide a clue — at least in a few months.

In an or­der signed Wednes­day, Biden de­mand­ed a 100-day gov­ern­men­tal re­view of key sup­ply chains, in­clud­ing for ac­tive phar­ma­ceu­ti­cal in­gre­di­ents (API) used in Amer­i­can drugs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER